A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 69,700 shares of GLUE stock, worth $497,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,700
Previous 11,700 495.73%
Holding current value
$497,658
Previous $43,000 758.14%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.59 - $6.97 $585,263 - $1.14 Million
163,026 Added 16.37%
1,158,969 $6.14 Million
Q2 2024

Aug 14, 2024

BUY
$3.38 - $7.86 $53,079 - $123,433
15,704 Added 1.6%
995,943 $3.72 Million
Q1 2024

May 15, 2024

SELL
$4.26 - $8.46 $15,105 - $29,999
-3,546 Reduced 0.36%
980,239 $6.91 Million
Q4 2023

Feb 14, 2024

BUY
$2.5 - $5.93 $382,937 - $908,327
153,175 Added 18.44%
983,785 $5.56 Million
Q3 2023

Nov 14, 2023

BUY
$4.78 - $7.22 $281,283 - $424,868
58,846 Added 7.62%
830,610 $3.98 Million
Q2 2023

Aug 14, 2023

BUY
$4.53 - $8.4 $7,986 - $14,809
1,763 Added 0.23%
771,764 $5.29 Million
Q1 2023

May 15, 2023

SELL
$5.95 - $8.21 $1.21 Million - $1.68 Million
-204,194 Reduced 20.96%
770,001 $6 Million
Q4 2022

Feb 14, 2023

BUY
$6.71 - $9.72 $142,513 - $206,443
21,239 Added 2.23%
974,195 $7.41 Million
Q3 2022

Nov 14, 2022

BUY
$7.17 - $12.16 $5.97 Million - $10.1 Million
833,124 Added 695.24%
952,956 $7.79 Million

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $334M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.